Precision Medicine Group made a major investment in Precision Advance earlier in 2021 through the acquisition of Project Farma, a bioengineering services firm that supports life sciences researchers. Project Farma specializes in planning and implementing complex biomanufacturing strategies, and has led the construction of more than a dozen manufacturing facilities.

Project Farma is now part of Precision for Medicine, Precision Medicine Group's research and development services arm, as well as Precision Advance, the company's dedicated cell and gene therapy business.

Learn more about Precision Advance, Project Farma, and Precision Medicine Group in this video.

Precision Medicine acquires Project Farma
Precision Medicine has acquired Project Farma, a bioengineering services firm.